Regulatory T cells, interleukin (IL)-6, IL-8, Vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma

Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis

(2012) Isabella Kanzler et al.   BASIC RESEARCH IN CARDIOLOGY

Interleukin-6 signaling pathway in targeted therapy for cancer

(2012) Yuqi Guo et al.   CANCER TREATMENT REVIEWS

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

(2012) Hai T Tran et al.   LANCET ONCOLOGY

Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients

(2012) Camillo Porta et al.   ONCOLOGY

Nox4 Mediates Renal Cell Carcinoma Cell Invasion through Hypoxia-Induced Interleukin 6- and 8- Production

(2012) John P. Fitzgerald et al.   PLoS One

Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs

(2011) Eyad Elkord et al.   CLINICAL IMMUNOLOGY

T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6

(2011) Kimberley A. Oldham et al.   EUROPEAN UROLOGY

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging

(2011) Judith Eckl et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

(2011) A Perier et al.   ONCOGENE

MetPA: a web-based metabolomics tool for pathway analysis and visualization

(2010) J. Xia et al.   BIOINFORMATICS

Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma

(2010) Francesco Liotta et al.   BJU INTERNATIONAL

Prognostic factors in renal cell carcinoma

(2010) Alessandro Volpe et al.   WORLD JOURNAL OF UROLOGY

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

(2009) Gordana Konjević et al.   BIOMARKERS

Natural Killer Cell IFN-  Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients

(2009) C. Menard et al.   CANCER RESEARCH

Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas

(2009) S. Attig et al.   CANCER RESEARCH

Targeted therapies in multiple myeloma

(2009) Efstathios Kastritis et al.   Targeted Oncology

The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma

(2008) Jin F. Li et al.   BJU INTERNATIONAL

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells

(2008) Paolo Carrega et al.   CANCER

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

The Blockade of IL-6 Signaling in Rational Drug Design

(2008) Yasuo Adachi et al.   CURRENT PHARMACEUTICAL DESIGN

The role of T-regulatory cells in pregnancy and cancer

(2007) Jacek et al.   Frontiers in Bioscience-Landmark

Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer

(2007) G. Esendagli et al.   LUNG CANCER